251 related articles for article (PubMed ID: 23504141)
1. Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials.
Wallace AM; Han LK; Povoski SP; Deck K; Schneebaum S; Hall NC; Hoh CK; Limmer KK; Krontiras H; Frazier TG; Cox C; Avisar E; Faries M; King DW; Christman L; Vera DR
Ann Surg Oncol; 2013 Aug; 20(8):2590-9. PubMed ID: 23504141
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma.
Sondak VK; King DW; Zager JS; Schneebaum S; Kim J; Leong SP; Faries MB; Averbook BJ; Martinez SR; Puleo CA; Messina JL; Christman L; Wallace AM
Ann Surg Oncol; 2013 Feb; 20(2):680-8. PubMed ID: 23054107
[TBL] [Abstract][Full Text] [Related]
3. Comparison of [(99m)Tc]tilmanocept and filtered [(99m)Tc]sulfur colloid for identification of SLNs in breast cancer patients.
Baker JL; Pu M; Tokin CA; Hoh CK; Vera DR; Messer K; Wallace AM
Ann Surg Oncol; 2015 Jan; 22(1):40-5. PubMed ID: 25069859
[TBL] [Abstract][Full Text] [Related]
4. A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer.
Leong SP; Kim J; Ross M; Faries M; Scoggins CR; Metz WL; Cope FO; Orahood RC
Ann Surg Oncol; 2011 Apr; 18(4):961-9. PubMed ID: 21331809
[TBL] [Abstract][Full Text] [Related]
5. Use of
Unkart JT; Wallace AM
J Nucl Med Technol; 2017 Sep; 45(3):181-184. PubMed ID: 28705929
[No Abstract] [Full Text] [Related]
6. The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the ⁹⁹mTc-labeled nanocolloid human serum albumin standard of care.
Tokin CA; Cope FO; Metz WL; Blue MS; Potter BM; Abbruzzese BC; Hartman RD; Joy MT; King DW; Christman LA; Vera DR; Wallace AM
Clin Exp Metastasis; 2012 Oct; 29(7):681-6. PubMed ID: 22729510
[TBL] [Abstract][Full Text] [Related]
7. Use of a novel receptor-targeted (CD206) radiotracer, 99mTc-tilmanocept, and SPECT/CT for sentinel lymph node detection in oral cavity squamous cell carcinoma: initial institutional report in an ongoing phase 3 study.
Marcinow AM; Hall N; Byrum E; Teknos TN; Old MO; Agrawal A
JAMA Otolaryngol Head Neck Surg; 2013 Sep; 139(9):895-902. PubMed ID: 24051744
[TBL] [Abstract][Full Text] [Related]
8. Tc-99m tilmanocept versus Tc-99m sulfur colloid in breast cancer sentinel lymph node identification: Results from a randomized, blinded clinical trial.
Unkart JT; Hosseini A; Wallace AM
J Surg Oncol; 2017 Dec; 116(7):819-823. PubMed ID: 28695567
[TBL] [Abstract][Full Text] [Related]
9. [(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial.
Agrawal A; Civantos FJ; Brumund KT; Chepeha DB; Hall NC; Carroll WR; Smith RB; Zitsch RP; Lee WT; Shnayder Y; Cognetti DM; Pitman KT; King DW; Christman LA; Lai SY
Ann Surg Oncol; 2015 Oct; 22(11):3708-15. PubMed ID: 25670018
[TBL] [Abstract][Full Text] [Related]
10.
Murphy BL; Woodwick AR; Murphy KM; Chandler KJ; Johnson GB; Hunt CH; Peller P; Jakub JW; Homb AC
J Nucl Med Technol; 2019 Dec; 47(4):300-304. PubMed ID: 31019032
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of "one-day" vs "two-day" injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancer.
Unkart JT; Proudfoot J; Wallace AM
Breast J; 2018 Jul; 24(4):526-530. PubMed ID: 29498443
[TBL] [Abstract][Full Text] [Related]
12. Sentinel Lymph Node Biopsy in Breast Cancer with
Vidal-Sicart S; Rioja ME; Prieto A; Goñi E; Gómez I; Albala MD; Lumbreras L; León LF; Gómez JR; Campos F
J Nucl Med; 2021 May; 62(5):620-627. PubMed ID: 33037087
[No Abstract] [Full Text] [Related]
13. Within-patient comparison between [
Mahieu R; Donders DNV; Krijger GC; Ververs FFT; de Roos R; Bemelmans JLMM; van Rooij R; de Bree R; de Keizer B
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):2023-2036. PubMed ID: 34962582
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node detection in oral cancer: a within-patient comparison between [
den Toom IJ; Mahieu R; van Rooij R; van Es RJJ; Hobbelink MGG; Krijger GC; Tijink BM; de Keizer B; de Bree R
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):851-858. PubMed ID: 32839855
[TBL] [Abstract][Full Text] [Related]
15. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
Kern KA
J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
[TBL] [Abstract][Full Text] [Related]
16. [99mTc]Tilmanocept Lymphscintigraphy after inconclusive [99mTc]Nanocolloid Scan in Breast Cancer.
Kircher M; Seifert S; Kircher S; Lapa C
Nuklearmedizin; 2019 Jun; 58(3):282-284. PubMed ID: 31064028
[TBL] [Abstract][Full Text] [Related]
17. Does
Rietbergen DD; Pereira Arias-Bouda LM; van der Hage J; Valdés Olmos RA
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(5):275-280. PubMed ID: 34425967
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
[TBL] [Abstract][Full Text] [Related]
19. Lymphoscintigraphy Using Tilmanocept Detects Multiple Sentinel Lymph Nodes in Melanoma Patients.
Balkin DM; Tranah GJ; Wang F; O'Donoghue C; Morell EA; Porubsky C; Nosrati M; Vaquero EM; Kim H; Carr MJ; Montilla-Soler JL; Wu MC; Torre DM; Kashani-Sabet M; Zager JS; Leong SP
Cancer Control; 2023; 30():10732748231153775. PubMed ID: 36705261
[TBL] [Abstract][Full Text] [Related]
20. Detection of melanoma, breast cancer and head and neck squamous cell cancer sentinel lymph nodes by Tc-99m Tilmanocept (Lymphoseek®).
Leong SP
Clin Exp Metastasis; 2022 Feb; 39(1):39-50. PubMed ID: 34962630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
